GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) » Definitions » 3-Year Revenue Growth Rate

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) 3-Year Revenue Growth Rate : 54.20% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Bio-Sincerity Pharma-Tech Co 3-Year Revenue Growth Rate?

Hangzhou Bio-Sincerity Pharma-Tech Co's Revenue per Share for the three months ended in Mar. 2024 was ¥1.99.

During the past 12 months, Hangzhou Bio-Sincerity Pharma-Tech Co's average Revenue per Share Growth Rate was 60.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 54.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 46.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Hangzhou Bio-Sincerity Pharma-Tech Co was 81.20% per year. The lowest was 38.40% per year. And the median was 52.65% per year.


Competitive Comparison of Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year Revenue Growth Rate falls into.



Hangzhou Bio-Sincerity Pharma-Tech Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Hangzhou Bio-Sincerity Pharma-Tech Co  (SZSE:301096) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Hangzhou Bio-Sincerity Pharma-Tech Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Business Description

Traded in Other Exchanges
N/A
Address
611 Dongguan Road, 2nd Floor, Building 8, Jinsheng Technology Park, Binjiang District, Hangzhou, CHN
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Headlines

No Headlines